Joe Biedenkapp

Joe is vice president, editing development at Verve Therapeutics. Working for nearly a decade in the biotechnology industry, Joe brings broad experience in early and late-stage drug development, basic and clinical research, medical affairs, alliance management, and program leadership. Prior to joining Verve, he was vice president, program, and portfolio management at Shape Therapeutics. Joe began his career in medical affairs at Dyax, followed by a number of roles in both medical affairs and program leadership at Bluebird Bio. He received his B.A. in philosophy from the University of Vermont, a PhD in neuroscience from the University of Colorado at Boulder and completed his post-doctoral studies at the Picower Institute for Learning and Memory at MIT and the US Army Research Institute for Environmental Medicine.